A recent FDA panel voted to recommend loosening regulations on six peptide treatments, which are increasingly marketed as medical and wellness solutions. This decision is expected to boost the market for peptides.
The market for peptides, chemicals that have been increasingly promoted as new medical treatments and wellness products, got a big boost this week as a divided Food and Drug Administration panel voted on Thursday and Friday to recommend loosening regulations on six peptide treatments.
